The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
12 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $1,895,821 in first-year total cost, median $165,618.
Most frequent study sections
- Special Emphasis Panel[ZCA1 RTRB-U (O1)]12
Most frequent institutions
- MASSACHUSETTS GENERAL HOSPITAL2
- BRIGHAM AND WOMEN'S HOSPITAL1
- BROAD INSTITUTE, INC.1
- DANA-FARBER CANCER INST1
- HARVARD UNIVERSITY D/B/A HARVARD SCHOOL OF PUBLIC HEALTH1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2024 | Large-scale artificial intelligence using radiomics, deep learning, and physics-based generative modeling to improve clinical outcomes in nuclear medicine1K99CA287045-01 | LEUNG, KEVIN HO-YIN | JOHNS HOPKINS UNIVERSITY, MD | $177,600 | ZCA1 |
| 2024 | Breaching the Tumor-Immune Mechanical Barrier for Optimal Antitumor Immunity1K99CA286969-01 | WU, BOGANG | MASSACHUSETTS GENERAL HOSPITAL, MA | $176,040 | ZCA1 |
| 2024 | Explainable Artificial Intelligence for Melanoma Recurrence Prediction via Integrative Modeling of Multiplexed Imaging with Transcriptomics and Histopathology1K99CA286966-01 | WAN, GUIHONG | MASSACHUSETTS GENERAL HOSPITAL, MA | $176,040 | ZCA1 |
| 2024 | A Chemoproteomic Approach to Identify Molecular Glues for Targeted Cancer Therapy1K99CA287069-01 | YOON, HOJONG | BROAD INSTITUTE, INC., MA | $171,180 | ZCA1 |
| 2024 | A multi-omics approach to evaluate the role of chronic inflammation in breast cancer development1K99CA286891-01 | ROMANOS-NANCLARES, ANDREA | BRIGHAM AND WOMEN'S HOSPITAL, MA | $168,890 | ZCA1 |
| 2024 | Quantitative modeling of extrachromosomal DNA (ecDNA) evolution in tumors1K99CA286968-01 | JONES, MATTHEW GREGORY | STANFORD UNIVERSITY, CA | $167,508 | ZCA1 |
| 2024 | Dissecting the Role of Germline Genetics in RAS-Driven Cancers1K99CA286805-01 | COLLINS, RYAN LEWIS | DANA-FARBER CANCER INST, MA | $163,728 | ZCA1 |
| 2024 | Influence of Social Determinants of Health and Epigenomics on Psychological Symptom Cluster Severity1K99CA286967-01 | HARRIS, CAROLYN STIGGE | UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA | $161,556 | ZCA1 |
| 2024 | Quantitatively predicting drug-resistant mutations to improve precision oncology1K99CA286801-01 | SINGH, SUKRIT | SLOAN-KETTERING INST CAN RESEARCH, NY | $144,056 | ZCA1 |
| 2024 | Dietary Control of the Pro-Metastatic Niche in Colorectal Cancer1K99CA287057-01 | GOSWAMI, SWAGATA | MASSACHUSETTS INSTITUTE OF TECHNOLOGY, MA | $142,301 | ZCA1 |
| 2024 | Learning about the effectiveness of lung cancer screening in real-world target populations1K99CA287059-01 | ROBERTSON, SARAH E | HARVARD UNIVERSITY D/B/A HARVARD SCHOOL OF PUBLIC HEALTH, MA | $128,881 | ZCA1 |
| 2024 | Elucidating the role of hepatic ketogenesis in pancreatic cancer cachexia and recovery1K99CA286709-01 | ARNESON-WISSINK, PAIGE C | OREGON HEALTH & SCIENCE UNIVERSITY, OR | $118,041 | ZCA1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-10-0.1.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.